Lake Street Maintains Buy on PetMed Express, Lowers Price Target to $7
Portfolio Pulse from Benzinga Newsdesk
Lake Street analyst Ryan Meyers maintains a Buy rating on PetMed Express (NASDAQ:PETS) but lowers the price target from $9 to $7.
June 12, 2024 | 6:21 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Lake Street analyst Ryan Meyers maintains a Buy rating on PetMed Express but lowers the price target from $9 to $7.
The Buy rating suggests continued confidence in the stock, but the lowered price target indicates a more cautious outlook on its short-term performance.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100